Hence, these tumors become refractory to TGF-β growth inhibition and the pro-tumorigenic actions of TGF-β may prevail, including immunosuppression, induction of angiogenesis and promotion of the EMT, thus facilitating cancer migration and invasion (reviewed in [27,46,47]). Here, TGFB1 is linked to cancer.